These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
326 related articles for article (PubMed ID: 9245560)
1. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis. Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560 [TBL] [Abstract][Full Text] [Related]
2. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats. Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203 [TBL] [Abstract][Full Text] [Related]
3. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension. Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343 [TBL] [Abstract][Full Text] [Related]
4. Increased renal expression of nitric oxide synthase type III in cirrhotic rats with ascites. Bosch-Marcé M; Morales-Ruiz M; Jiménez W; Bordas N; Solé M; Ros J; Deulofeu R; Arroyo V; Rivera F; Rodés J Hepatology; 1998 May; 27(5):1191-9. PubMed ID: 9581670 [TBL] [Abstract][Full Text] [Related]
5. [Nitric oxide in pathogenesis of cirrhotic portal hypertension in rats and its hemodynamic effects]. Zhang J; Zhou H Zhonghua Wai Ke Za Zhi; 1998 May; 36(5):317-9. PubMed ID: 11825400 [TBL] [Abstract][Full Text] [Related]
6. Role of nitric oxide synthase and cyclooxygenase in hyperdynamic splanchnic circulation of portal hypertension. Xu J; Cao H; Liu H; Wu ZY Hepatobiliary Pancreat Dis Int; 2008 Oct; 7(5):503-8. PubMed ID: 18842497 [TBL] [Abstract][Full Text] [Related]
7. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats. Wang H; Chen XP; Qiu FZ Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946 [TBL] [Abstract][Full Text] [Related]
8. Ablation of primary afferent neurons by neonatal capsaicin treatment reduces the susceptibility of the portal hypertensive gastric mucosa to ethanol-induced injury in cirrhotic rats. Camara PR; Ferraz GJ; Franco-Penteado CF; Sbragia-Neto L; Meirelles LR; Teixeira SA; Muscara MN; Velloso LA; Antunes E; Ferraz JG Eur J Pharmacol; 2008 Jul; 589(1-3):245-50. PubMed ID: 18555214 [TBL] [Abstract][Full Text] [Related]
9. Increased nitric oxide synthase expression in arterial vessels of cirrhotic rats with ascites. Morales-Ruiz M; Jiménez W; Pérez-Sala D; Ros J; Leivas A; Lamas S; Rivera F; Arroyo V Hepatology; 1996 Dec; 24(6):1481-6. PubMed ID: 8938184 [TBL] [Abstract][Full Text] [Related]
10. Increased blood flow through the portal system in cirrhotic rats. Vorobioff J; Bredfeldt JE; Groszmann RJ Gastroenterology; 1984 Nov; 87(5):1120-6. PubMed ID: 6479534 [TBL] [Abstract][Full Text] [Related]
11. [Experimental study on iNOS gene transfer mediated by liposome to treat portal hypertension in cirrhotic rats]. Qiu JF; Wu ZY; Zhang ZQ; Luo HF Zhonghua Wai Ke Za Zhi; 2004 Apr; 42(7):428-31. PubMed ID: 15144673 [TBL] [Abstract][Full Text] [Related]
13. Splanchnic endotoxin levels in cirrhotic rats induced by carbon tetrachloride. Chu CJ; Lee FY; Wang SS; Chang FY; Lin HC; Lu RH; Chan CC; Lee SD Zhonghua Yi Xue Za Zhi (Taipei); 2000 Mar; 63(3):196-204. PubMed ID: 10746415 [TBL] [Abstract][Full Text] [Related]
14. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats]. Albornoz L; Bandi JC; de las Heras M; Mastai R Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955 [TBL] [Abstract][Full Text] [Related]
15. [Role of nitric oxide in alterations of the systemic and splanchnic hemodynamics in a experimental model of portal hypertension]. Albornoz L; Bandi JC; Sánchez S; Spinedi E; Canteros G; De Paula JA; Galdame O; Mastai R Medicina (B Aires); 1994; 54(1):17-24. PubMed ID: 7990681 [TBL] [Abstract][Full Text] [Related]
16. Tyrosine kinase inhibition ameliorates the hyperdynamic state and decreases nitric oxide production in cirrhotic rats with portal hypertension and ascites. López-Talavera JC; Levitzki A; Martínez M; Gazit A; Esteban R; Guardia J J Clin Invest; 1997 Aug; 100(3):664-70. PubMed ID: 9239414 [TBL] [Abstract][Full Text] [Related]
18. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats. Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709 [TBL] [Abstract][Full Text] [Related]
19. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: implications for regulation of portal pressure and resistance. Rockey DC; Weisiger RA Hepatology; 1996 Jul; 24(1):233-40. PubMed ID: 8707268 [TBL] [Abstract][Full Text] [Related]
20. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance. Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]